Screener / SEC EDGAR /CIK 0000046250 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Chemicals & Allied Products

Hawkins Inc HWKN

Compare with peers Embed
Earnings releases

Latest results release: Oct 26, 2026

8-K item 2.02, exhibit 99
Latest release Oct 26, 2026 Second Quarter Fiscal 2027 Results
Releases kept 12 12 documents, oldest Jan 31, 2024

What HWKN's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 26, 2026 · EX-99.1

Second Quarter Fiscal 2027 Results

Open on SEC

Roseville, Minn., October 26, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for its second quarter of fiscal 2027, the three months ended September 27, 2026. Second Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the second quarter of fiscal 2026 unless otherwise noted.) • Record second quarter revenue of $313.8 million, with growth of 12%, driven by increased sales across all segments, including Water Treatment segment growth of 16%, Food & Health Sciences segment growth of 5%, and Industrial Solutions segment growth of 10%.

• Record second quarter diluted earnings per share ("EPS") of $1.34 increased $0.25, or 23%.

• Record second quarter net income of $27.8 million increased 23%, with record trailing twelve-month net income of $85.8 million. Record Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $59.1 million, a 16% increase. Record trailing twelve-month adjusted EBITDA of $188.0 million.

• Generated operating cash flow of $75.5 million, an increase of 6% for the six months ended September 27, 2026 . Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased 14% to $53.1 million compared to the same period in the prior year, which we allocated to repurchasing $18.6 million of stock, paying down $15.0 million of debt and paying $8.1 million in dividends.

• Closed our second acquisition of fiscal 2027 with the purchase of Dave Symonds & Associates, Inc., a blended phosphates for corrosion control and sequestration focused water distributor based in Florida.

• Subsequent to quarter end, we expanded into the Dallas–Fort Worth region, pairing our greenfield Water Treatment facility with the acquisition of Eagle Labs, Inc., a water treatment distributor with in-house manufacturing capabilities and expertise in coagulants and polymers.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our record second-quarter results in revenue, gross profit, EPS, and adjusted EBITDA reflect the agility of our employees and the resilience of our business model,” said Patrick Hawkins, President and Chief Executive Officer. “Revenue grew 12% in the quarter, including organic growth of 11%, with all three segments growing and Water Treatment revenue up 16%, primarily driven by increased volumes. Gross profit grew 13%, again led by Water Treatment at 20%, driven by volume growth and higher per-unit dollar margins. That gross profit growth flowed through to the bottom line, with diluted EPS up 23% and record adjusted EBITDA of $59 million, up 16%.”

Mr. Hawkins continued, “We continue to generate strong cash flow. During the quarter, we repurchased $12 million of our stock, paid down $15 million of debt, and closed on the acquisition of Dave Symonds & Associates, a tuck-in that expands our Water Treatment customer reach in Florida. Our leverage ratio at the end of the second quarter was 1.22x adjusted EBITDA, down from 1.37x at the end of fiscal 2026 and 1.54x in the same quarter last year. Subsequent to quarter end, we closed on the acquisition of Eagle Labs, which adds two locations in the Dallas–Fort Worth region, continuing our expansion in Texas. We will continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and serving the needs of our customers to the highest level possible.”

Mr. Hawkins concluded, “Looking forward we expect the second half trends to be consistent with what we saw in the first half, recognizing that SG&A in the second half of fiscal 2026 benefited from a non-recurring $6.2 million reduction in SG&A which will not recur in the second half of fiscal 2027.”

For the second quarter of fiscal 2027, we reported net income of $27.8 million, or $1.34 per diluted share, compared to net income for the second quarter of fiscal 2026 of $22.6 million, or $1.08 per diluted share.

Sales were $313.8 million for the second quarter of fiscal 2027, an increase of $33.4 million, or 12%, from sales of $280.4 million in the same period a year ago. All of our segments grew by 5% or more from the same period a year ago. Sales increased as a result of 11% organic sales growth and approximately $3.7 million of sales from acquired businesses.

Water Treatment segment sales increased $24.1 million, or 16%, to $175.0 million for the current quarter, from $150.9 million in the same period a year ago. Organic sales grew 14%, driven primarily by increased volumes, along with improved pricing on certain of our products. Growth was broad-based across our product lines and end markets, with the municipal end market particularly strong. Acquired businesses contributed approximately $3.7 million in additional sales.

Food & Health Sciences segment sales increased $3.8 million, or 5%, to $76.7 million for the current quarter, from $72.9 million in the same period a year ago. Sales dollars increased as a result of increased volumes of our nutrition, food ingredients, and pharmaceutical products, partially offset by decreased sales of our agricultural products.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $62.2 million for the current quarter, from $56.6 million in the same period a year ago. Sales increased as a result of improved pricing and favorable product mix, which more than offset lower volumes.

Gross profit increased $9.0 million, or 13%, to $76.6 million, or 24% of sales, for the current quarter, from $67.6 million, or 24% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million due to higher raw material costs. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.3 million. The $1.6 million year-over-year impact of the unfavorable LIFO reserve was partially offset by $1.3 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The refunded tariffs related to products for which customer pricing had not been increased in response to tariffs. Gross profit was also pressured by higher fuel costs that were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $8.4 million, or 20%, to $51.7 million, or 30% of sales, for the current quarter, from $43.3 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.5 million. In the same period a year ago, the LIFO reserve decreased, and gross profit increased minimally. The $0.5 million year-over-year impact of the unfavorable LIFO reserve was more than offset by $1.2 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The increase in gross profit was primarily driven by higher sales.

Gross profit for the Food & Health Sciences segment decreased $0.6 million, or 4%, to $14.9 million, or 19% of sales, for the current quarter, from $15.5 million, or 21% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.2 million. Gross profit decreased as lower margins in our food and pharmaceutical products and the $0.5 million year-over-year impact of the unfavorable LIFO reserve more than offset the benefit of higher segment sales and improved margins in our nutrition and agriculture products.

Gross profit for the Industrial Solutions segment increased $1.1 million, or 12%, to $10.0 million, or 16% of sales, for the current quarter, from $8.9 million, or 16% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.1 million. The benefit of higher sales and favorable product mix was partially offset by the $0.6 million year-over-year impact of the unfavorable LIFO reserve.

Selling, general and administrative (“SG&A”) expenses increased $1.0 million, or 3%, to $34.7 million, or 11% of sales, for the three months ended September 27, 2026, from $33.7 million, or 12% of sales, in the same period a year ago. This included $0.4 million due to added costs from the acquired businesses in our Water Treatment segment. SG&A expenses also increased due to increases in other variable costs, including variable pay and other personnel costs. These increases were partially offset by a $0.5 million decrease in non-qualified deferred compensation plan expense, as appreciation in the market value of plan investments was lower than in the same period a year ago. Deferred compensation plan expense is offset by a corresponding gain on plan investments recorded in other income (expense).

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended September 27, 2026 was $59.1 million, an increase of $8.2 million, or 16%, from $50.9 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended September 28, 2025 was $50.4 million, which included non-cash earnout related expense that is excluded under the current definition.

Our effective income tax rate was 30% for the current quarter and 27% for the same period a year ago. The effective income tax rate for each period exceeded the U.S. federal statutory rate of 21%, primarily due to state income taxes on non-deductible expenses, including executive compensation and other permanent items. The increase in the effective income tax rate compared with prior-periods was primarily due to higher state income taxes and an increase in non-deductible items. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, state taxes and discrete items, including tax effects of stock-based compensation. Our effective tax rate for the full year is expected to be approximately 25% to 27%.

As of September 27, 2026, our working capital was $18 million higher than the end of fiscal 2026 due primarily to increased trade receivables and inventory, partially offset by an increase in payables. Our total debt outstanding at the end of the second quarter was $229.0 million, and our leverage ratio was 1.22x our trailing twelve-month adjusted EBITDA, as compared to 1.37x our trailing twelve-month adjusted EBITDA at the end of fiscal 2026.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences, and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 69 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA and free cash flow. These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses these non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation, charges for the employee stock purchase plan and restricted stock grants, non-recurring items of income or expense, and earnout related expense or income. The non-cash earnout related expense or income adjustment was added to our definition in the third quarter of fiscal 2026 to better reflect results from operations. Prior period amounts have been recast to conform to the current definition.

We define free cash flow as net cash provided by operating activities less purchases of property, plant, and equipment. Management believes free cash flow is a useful measure of the cash generated by our business that is available for, among other things, debt repayment, acquisitions, dividends, and share repurchases.

(1) Acquisition expenses consist of legal, professional, and other direct costs incurred in connection with business acquisitions. These costs are transaction- specific and not part of normal recurring operations.

September 27, March 29, 2026 2026 ────────────────────────────────────────────────────────────────────────────── ASSETS CURRENT ASSETS: Cash and cash equivalents $ 7,100 $ 3,914 Trade accounts receivables, net 149,281 139,796 Inventories 92,947 78,199 Prepaid expenses and other current 7,793 9,556 assets Total current assets 257,121 231,465 Property, plant, and equipment 509,360 489,662 Less accumulated depreciation 237,614 223,406 Net property, plant, and equipment 271,746 266,256 OTHER ASSETS: Right-of-use assets, net 17,170 16,840 Goodwill 224,439 223,042 Intangible assets, net 224,455 232,887 Deferred compensation plan asset 15,649 12,812 Other 1,472 2,988 Total other assets 483,185 488,569 Total assets $ 1,012,052 $ 986,290 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable — trade $ 69,609 $ 59,835 Accrued payroll and employee benefits 15,746 20,092 Income tax payable 5,025 98 Environmental remediation 7,700 7,700 Other current liabilities 14,676 17,119 Total current liabilities 112,756 104,844 LONG-TERM LIABILITIES: Long-term debt 229,000 244,000 Long-term lease liabilities 14,699 14,457 Pension withdrawal liability 2,563 2,763 Deferred income taxes 26,143 25,110 Deferred compensation liability 16,941 14,850 Earnout liabilities 45,985 44,898 Other long-term liabilities 276 1,359 Total long-term liabilities 335,607 347,437 Total liabilities $ 448,363 $ 452,281 COMMITMENTS AND CONTINGENCIES SHAREHOLDERS' EQUITY: Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,674,812 and 20,752,138 shares issued 207 208 and outstanding as of September 27, 2026 and March 29, 2026, respectively Additional paid-in capital 14,739 32,678 Retained earnings 548,041 500,142 Accumulated other comprehensive income 702 981 Total shareholders’ equity 563,689 534,009 Total liabilities and shareholders’ $ 1,012,052 $ 986,290 equity

September 27, September 28, Six months ended 2026 2025 ────────────────────────────────────────────────────────────────────────────── CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 56,035 $ 51,773 Reconciliation to cash flows: Depreciation and 28,240 25,553 amortization Change in fair value of earnout 1,087 -1,048 liabilities Operating leases 2,121 1,881 Gain on deferred -1,689 -1,664 compensation assets Deferred income taxes 1,131 — Stock compensation 4,168 4,587 expense Other, net -60 8 Changes in operating accounts providing (using) cash: Trade receivables -9,949 5,140 Inventories -14,550 -5,196 Accounts payable 9,676 -11,013 Accrued liabilities -6,320 -4,209 Lease liabilities -2,376 -1,897 Income taxes 5,173 4,082 Other, net 2,801 3,034 Net cash provided by operating 75,488 71,031 activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property, plant, and -22,355 -24,342 equipment Acquisitions -5,200 -162,508 Proceeds from asset 517 1,037 disposals Net cash used in -27,038 -185,813 investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividends -8,136 -7,723 declared and paid New shares issued 1,681 1,609 Payroll taxes paid in exchange for -5,143 -3,028 shares withheld Shares repurchased -18,646 — Payments on senior secured revolving -20,000 -40,000 loan Payments for debt — -764 issuance costs Borrowings on senior secured revolving 5,000 170,000 loan Other -20 — Net cash (used in) provided by financing -45,264 120,094 activities NET INCREASE IN CASH AND CASH 3,186 5,312 EQUIVALENTS CASH AND CASH EQUIVALENTS, 3,914 5,103 BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF $ 7,100 $ 10,415 PERIOD SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Cash paid for income $ 14,512 $ 13,980 taxes Cash paid for $ 5,480 $ 7,182 interest Noncash investing activities - capital $ 2,273 $ 1,568 expenditures in accounts payable

Forward-Looking Statements . Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, changes in product supplies, the availability of target acquisitions, and changes in interest rates. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 29, 2026 , as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements. Contacts: Jack Shufelt

Full text with the tables
                
  Exhibit 99.1  
                
                                                                                
                             Hawkins, Inc. Reports                              
                                                                                
                                                                                
                       Second Quarter Fiscal 2027 Results                       
                                                                                
Roseville, Minn., October 26, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today
announced results for its second quarter of fiscal 2027, the three months ended
September 27, 2026.
Second Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the second quarter of fiscal 2026 unless otherwise
noted.)
• Record second quarter revenue of $313.8 million, with growth of 12%, driven by
increased sales across all segments, including Water Treatment segment growth of
16%, Food & Health Sciences segment growth of 5%, and Industrial Solutions
segment growth of 10%.

• Record second quarter gross profit of $76.6 million, an increase of 13%.

• Record second quarter diluted earnings per share ("EPS") of $1.34 increased
$0.25, or 23%.

• Record second quarter net income of $27.8 million increased 23%, with record
trailing twelve-month net income of $85.8 million. Record Adjusted Earnings
Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a
non-GAAP measure, of $59.1 million, a 16% increase. Record trailing twelve-month
adjusted EBITDA of $188.0 million.

• Generated operating cash flow of $75.5 million, an increase of 6% for the six
months ended September 27, 2026 . Free cash flow, defined as net cash provided
by operating activities less capital expenditures, increased 14% to $53.1
million compared to the same period in the prior year, which we allocated to
repurchasing $18.6 million of stock, paying down $15.0 million of debt and
paying $8.1 million in dividends.

• Closed our second acquisition of fiscal 2027 with the purchase of Dave Symonds
& Associates, Inc., a blended phosphates for corrosion control and sequestration
focused water distributor based in Florida.

• Subsequent to quarter end, we expanded into the Dallas–Fort Worth region,
pairing our greenfield Water Treatment facility with the acquisition of Eagle
Labs, Inc., a water treatment distributor with in-house manufacturing
capabilities and expertise in coagulants and polymers.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and
President:

“Our record second-quarter results in revenue, gross profit, EPS, and adjusted
EBITDA reflect the agility of our employees and the resilience of our business
model,” said Patrick Hawkins, President and Chief Executive Officer. “Revenue
grew 12% in the quarter, including organic growth of 11%, with all three
segments growing and Water Treatment revenue up 16%, primarily driven by
increased volumes. Gross profit grew 13%, again led by Water Treatment at 20%,
driven by volume growth and higher per-unit dollar margins. That gross profit
growth flowed through to the bottom line, with diluted EPS up 23% and record
adjusted EBITDA of $59 million, up 16%.”

Mr. Hawkins continued, “We continue to generate strong cash flow. During the
quarter, we repurchased $12 million of our stock, paid down $15 million of debt,
and closed on the acquisition of Dave Symonds & Associates, a tuck-in that
expands our Water Treatment customer reach in Florida. Our leverage ratio at the
end of the second quarter was 1.22x adjusted EBITDA, down from 1.37x at the end
of fiscal 2026 and 1.54x in the same quarter last year. Subsequent to quarter
end, we closed on the acquisition of Eagle Labs, which adds two locations in the
Dallas–Fort Worth region, continuing our expansion in Texas. We will continue to
deliver on our strategy of investing in our higher-margin businesses, acquiring
companies that are accretive to Hawkins, and serving the needs of our customers
to the highest level possible.”

Mr. Hawkins concluded, “Looking forward we expect the second half trends to be
consistent with what we saw in the first half, recognizing that SG&A in the
second half of fiscal 2026 benefited from a non-recurring $6.2 million reduction
in SG&A which will not recur in the second half of fiscal 2027.”

Second Quarter Financial Highlights:
                                                                                
  NET INCOME                                                                    
                                                                                
For the second quarter of fiscal 2027, we reported net income of $27.8 million,
or $1.34 per diluted share, compared to net income for the second quarter of
fiscal 2026 of $22.6 million, or $1.08 per diluted share.
                                                                                
  REVENUE                                                                       
                                                                                
Sales were $313.8 million for the second quarter of fiscal 2027, an increase of
$33.4 million, or 12%, from sales of $280.4 million in the same period a year
ago. All of our segments grew by 5% or more from the same period a year ago.
Sales increased as a result of 11% organic sales growth and approximately $3.7
million of sales from acquired businesses.

Water Treatment segment sales increased $24.1 million, or 16%, to $175.0 million
for the current quarter, from $150.9 million in the same period a year ago.
Organic sales grew 14%, driven primarily by increased volumes, along with
improved pricing on certain of our products. Growth was broad-based across our
product lines and end markets, with the municipal end market particularly
strong. Acquired businesses contributed approximately $3.7 million in additional
sales.

Food & Health Sciences segment sales increased $3.8 million, or 5%, to $76.7
million for the current quarter, from $72.9 million in the same period a year
ago. Sales dollars increased as a result of increased volumes of our nutrition,
food ingredients, and pharmaceutical products, partially offset by decreased
sales of our agricultural products.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $62.2
million for the current quarter, from $56.6 million in the same period a year
ago. Sales increased as a result of improved pricing and favorable product mix,
which more than offset lower volumes.
                                                                                
  GROSS PROFIT                                                                  
                                                                                
Gross profit increased $9.0 million, or 13%, to $76.6 million, or 24% of sales,
for the current quarter, from $67.6 million, or 24% of sales, in the same period
a year ago. During the current quarter, the LIFO reserve increased, and gross
profit decreased, by $1.9 million due to higher raw material costs. In the same
period a year ago, the LIFO reserve increased, and gross profit decreased, by
$0.3 million. The $1.6 million year-over-year impact of the unfavorable LIFO
reserve was partially offset by $1.3 million of refunds of previously paid
tariffs, which were recorded as a reduction of cost of sales. The refunded
tariffs related to products for which customer pricing had not been increased in
response to tariffs. Gross profit was also pressured by higher fuel costs that
were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $8.4 million, or 20%, to
$51.7 million, or 30% of sales, for the current quarter, from $43.3 million, or
29% of sales, in the same period a year ago. During the current quarter, the
LIFO reserve increased, and gross profit decreased, by $0.5 million. In the same
period a year ago, the LIFO reserve decreased, and gross profit increased
minimally. The $0.5 million year-over-year impact of the unfavorable LIFO
reserve was more than offset by $1.2 million of refunds of previously paid
tariffs, which were recorded as a reduction of cost of sales. The increase in
gross profit was primarily driven by higher sales.

Gross profit for the Food & Health Sciences segment decreased $0.6 million, or
4%, to $14.9 million, or 19% of sales, for the current quarter, from $15.5
million, or 21% of sales, in the same period a year ago. During the current
quarter, the LIFO reserve increased, and gross profit decreased, by $0.7
million. In the same period a year ago, the LIFO reserve increased, and gross
profit decreased, by $0.2 million. Gross profit decreased as lower margins in
our food and pharmaceutical products and the $0.5 million year-over-year impact
of the unfavorable LIFO reserve more than offset the benefit of higher segment
sales and improved margins in our nutrition and agriculture products.

Gross profit for the Industrial Solutions segment increased $1.1 million, or
12%, to $10.0 million, or 16% of sales, for the current quarter, from $8.9
million, or 16% of sales, in the same period a year ago. During the current
quarter, the LIFO reserve increased, and gross profit decreased, by $0.7
million. In the same period a year ago, the LIFO reserve increased, and gross
profit decreased, by $0.1 million. The benefit of higher sales and favorable
product mix was partially offset by the $0.6 million year-over-year impact of
the unfavorable LIFO reserve.
                                                                                
  SELLING, GENERAL AND ADMINISTRATIVE EXPENSES                                  
                                                                                
Selling, general and administrative (“SG&A”) expenses increased $1.0 million, or
3%, to $34.7 million, or 11% of sales, for the three months ended September 27,
2026, from $33.7 million, or 12% of sales, in the same period a year ago. This
included $0.4 million due to added costs from the acquired businesses in our
Water Treatment segment. SG&A expenses also increased due to increases in other
variable costs, including variable pay and other personnel costs. These
increases were partially offset by a $0.5 million decrease in non-qualified
deferred compensation plan expense, as appreciation in the market value of plan
investments was lower than in the same period a year ago. Deferred compensation
plan expense is offset by a corresponding gain on plan investments recorded in
other income (expense).
                                                                                
  ADJUSTED EBITDA                                                               
                                                                                
Adjusted EBITDA, a non-GAAP financial measure, is an important performance
indicator and a key compliance measure under the terms of our credit agreement.
An explanation of the computation of adjusted EBITDA is presented below.
Adjusted EBITDA for the three months ended September 27, 2026 was $59.1 million,
an increase of $8.2 million, or 16%, from $50.9 million in the same period a
year ago. In the third quarter of fiscal 2026, we revised our definition of
adjusted EBITDA to exclude non-cash earnout related expense and income, in order
to better reflect results from operations. Prior-year adjusted EBITDA has been
recast in accordance with the current definition. As originally reported,
adjusted EBITDA for the three months ended September 28, 2025 was $50.4 million,
which included non-cash earnout related expense that is excluded under the
current definition.
                                                                                
  INCOME TAXES                                                                  
                                                                                
Our effective income tax rate was 30% for the current quarter and 27% for the
same period a year ago. The effective income tax rate for each period exceeded
the U.S. federal statutory rate of 21%, primarily due to state income taxes on
non-deductible expenses, including executive compensation and other permanent
items. The increase in the effective income tax rate compared with prior-periods
was primarily due to higher state income taxes and an increase in non-deductible
items. The effective tax rate is impacted by projected levels of annual taxable
income, permanent items, state taxes and discrete items, including tax effects
of stock-based compensation. Our effective tax rate for the full year is
expected to be approximately 25% to 27%.
                                                                                
  BALANCE SHEET                                                                 
                                                                                
As of September 27, 2026, our working capital was $18 million higher than the
end of fiscal 2026 due primarily to increased trade receivables and inventory,
partially offset by an increase in payables. Our total debt outstanding at the
end of the second quarter was $229.0 million, and our leverage ratio was 1.22x
our trailing twelve-month adjusted EBITDA, as compared to 1.37x our trailing
twelve-month adjusted EBITDA at the end of fiscal 2026.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty
ingredients company that formulates, manufactures, distributes, and blends
products for its Water Treatment, Food & Health Sciences, and Industrial
Solutions customers. Headquartered in Roseville, Minnesota, the Company has 69
facilities in 28 states and creates value for its customers through superb
customer service and support, quality products and personalized applications.
Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and
has approximately 1,200 employees. For more information, including registering
to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally
accepted accounting principles (GAAP). To assist investors in understanding our
financial performance between periods, we have provided certain financial
measures not computed according to GAAP, including adjusted EBITDA and free cash
flow. These non-GAAP financial measures are not meant to be considered in
isolation or as a substitute for comparable GAAP measures. The method we use to
produce non-GAAP results is not computed according to GAAP and may differ from
the methods used by other companies.

Management uses these non-GAAP financial measures internally to understand,
manage and evaluate our business and to make operating decisions. Management
believes that these non-GAAP financial measures reflect an additional way of
viewing aspects of our operations that, when viewed with our GAAP results,
provide a more complete understanding of the factors and trends affecting our
financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the
following: net interest expense resulting from our net borrowing position;
income tax expense; non-cash expenses including amortization of intangibles,
depreciation, charges for the employee stock purchase plan and restricted stock
grants, non-recurring items of income or expense, and earnout related expense or
income. The non-cash earnout related expense or income adjustment was added to
our definition in the third quarter of fiscal 2026 to better reflect results
from operations. Prior period amounts have been recast to conform to the current
definition.

We define free cash flow as net cash provided by operating activities less
purchases of property, plant, and equipment. Management believes free cash flow
is a useful measure of the cash generated by our business that is available for,
among other things, debt repayment, acquisitions, dividends, and share
repurchases.
                                                                                
                                                                   Trai…        
              Three  Sep…       Sept…    Six   Sept…       Sep…    Twel…  Sep…  
  Adj…  (In   mont…   27,         28,    mon…    27,        28,    mont…   27,  
  EBI…  tho…  ended  2026        2025    end…   2026       2025    ended  2026  
 ────────────────────────────────────────────────────────────────────────────── 
  Net                                                                           
  Inc…        $      27,…    $  22,5…    $     56,0…    $  51,…    $      85,…  
  (GA…                                                                          
  Int…                                                                          
  exp…               2,6…       3,832          5,416       7,1…           11,…  
  net                                                                           
  Inc…                                                                          
  tax                11,…       8,231          20,8…       18,…           30,…  
  exp…                                                                          
  Amo…                                                                          
  of                 5,5…       5,527          11,0…       10,…           21,…  
  int…                                                                          
  Dep…               8,7…       7,735          17,2…       15,…           33,…  
  exp…                                                                          
  Non…                                                                          
  com…               1,9…       2,375          4,168       4,5…           8,1…  
  exp…                                                                          
  Non…                                                                          
  acq…                140          70            203        940            501  
  exp…                                                                          
  Non…                                                                          
  ear…                                                                          
  rel…                552         535          1,087       -1,…           -4,…  
  exp…                                                                          
  (in…                                                                          
  Adj…        $      59,…    $  50,9…    $     115,…    $  106…    $      188…  
  EBI…                                                                          
                                                                                
(1) Acquisition expenses consist of legal, professional, and other direct costs
incurred in connection with business acquisitions. These costs are transaction-
specific and not part of normal recurring operations.
                                                                                
  Free Cash                                                          September  
  Flow          (In            Six months     September 27,                28,  
  Reconciliat…  thousands)     ended                   2026               2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Net cash                                                                      
  provided by                  $                     75,488    $        71,031  
  operating                                                                     
  activities                                                                    
  Less:                                                                         
  Purchases of                                                                  
  property,                                         -22,355            -24,342  
  plant &                                                                       
  equipment                                                                     
  Free cash                    $                     53,133    $        46,689  
  flow                                                                          
                                                                                
                                                                                
                                 HAWKINS, INC.                                  
                                                                                
                                                                                
                 CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)                  
                                                                                
                (In thousands, except share and per-share data)                 
                                                                                
            Three    Septem…       Septem…    Six       Septem…       Septemb…  
            months       27,           28,    months        27,            28,  
            ended       2026          2025    ended        2026           2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Sales     $        313,817    $  280,434    $         629,492    $   573,706  
  Cost                                                                          
  of                 -237,2…       -212,7…              -478,8…       -433,701  
  sales                                                                         
  Gross               76,606        67,643              150,613        140,005  
  profit                                                                        
  Selli…                                                                        
  gener…                                                                        
  and                -34,700       -33,703              -70,035        -64,732  
  admin…                                                                        
  expen…                                                                        
  Opera…              41,906        33,940               80,578         75,273  
  income                                                                        
  Inter…                                                                        
  expen…              -2,643        -3,832               -5,416         -7,101  
  net                                                                           
  Other                  264           721                1,689          1,663  
  income                                                                        
  Income                                                                        
  before              39,527        30,829               76,851         69,835  
  income                                                                        
  taxes                                                                         
  Income                                                                        
  tax                -11,746        -8,231              -20,816        -18,062  
  expen…                                                                        
  Net       $         27,781    $   22,598    $          56,035    $    51,773  
  income                                                                        
  Weigh…                                                                        
  avera…                                                                        
  number                                                                        
  of                 20,710…       20,737…              20,743…       20,727,…  
  shares                                                                        
  outst…                                                                        
  -                                                                             
  basic                                                                         
  Weigh…                                                                        
  avera…                                                                        
  number                                                                        
  of                 20,783…       20,845…              20,827…       20,837,…  
  shares                                                                        
  outst…                                                                        
  -                                                                             
  dilut…                                                                        
  Basic                                                                         
  earni…    $           1.34    $     1.09    $            2.70    $      2.50  
  per                                                                           
  share                                                                         
  Dilut…                                                                        
  earni…    $           1.34    $     1.08    $            2.69    $      2.48  
  per                                                                           
  share                                                                         
  Cash                                                                          
  divid…                                                                        
  decla…    $           0.20    $     0.19    $            0.39    $      0.37  
  per                                                                           
  common                                                                        
  share                                                                         
                                                                                
                                                                                
                                 HAWKINS, INC.                                  
                                                                                
                                                                                
               CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)                
                                                                                
                       (In thousands, except share data)                        
                                                                                
                                                 September 27,       March 29,  
                                                          2026            2026  
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  CURRENT ASSETS:                                                               
  Cash and cash equivalents                   $          7,100    $      3,914  
  Trade accounts receivables, net                      149,281         139,796  
  Inventories                                           92,947          78,199  
  Prepaid expenses and other current                     7,793           9,556  
  assets                                                                        
  Total current assets                                 257,121         231,465  
  Property, plant, and equipment                       509,360         489,662  
  Less accumulated depreciation                        237,614         223,406  
  Net property, plant, and equipment                   271,746         266,256  
  OTHER ASSETS:                                                                 
  Right-of-use assets, net                              17,170          16,840  
  Goodwill                                             224,439         223,042  
  Intangible assets, net                               224,455         232,887  
  Deferred compensation plan asset                      15,649          12,812  
  Other                                                  1,472           2,988  
  Total other assets                                   483,185         488,569  
  Total assets                                $      1,012,052    $    986,290  
  LIABILITIES AND SHAREHOLDERS’ EQUITY                                          
  CURRENT LIABILITIES:                                                          
  Accounts payable — trade                    $         69,609    $     59,835  
  Accrued payroll and employee benefits                 15,746          20,092  
  Income tax payable                                     5,025              98  
  Environmental remediation                              7,700           7,700  
  Other current liabilities                             14,676          17,119  
  Total current liabilities                            112,756         104,844  
  LONG-TERM LIABILITIES:                                                        
  Long-term debt                                       229,000         244,000  
  Long-term lease liabilities                           14,699          14,457  
  Pension withdrawal liability                           2,563           2,763  
  Deferred income taxes                                 26,143          25,110  
  Deferred compensation liability                       16,941          14,850  
  Earnout liabilities                                   45,985          44,898  
  Other long-term liabilities                              276           1,359  
  Total long-term liabilities                          335,607         347,437  
  Total liabilities                           $        448,363    $    452,281  
  COMMITMENTS AND CONTINGENCIES                                                 
  SHAREHOLDERS' EQUITY:                                                         
  Common stock; authorized:                                                     
  60,000,000 shares of $0.01 par value;                                         
  20,674,812 and 20,752,138 shares issued                  207             208  
  and outstanding as of September 27, 2026                                      
  and March 29, 2026, respectively                                              
  Additional paid-in capital                            14,739          32,678  
  Retained earnings                                    548,041         500,142  
  Accumulated other comprehensive income                   702             981  
  Total shareholders’ equity                           563,689         534,009  
  Total liabilities and shareholders’         $      1,012,052    $    986,290  
  equity                                                                        
                                                                                
                                                                                
                                 HAWKINS, INC.                                  
                                                                                
          CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)           
                                                                                
                                 (In thousands)                                 
                                                                                
                                             September 27,       September 28,  
                           Six months ended           2026                2025  
 ────────────────────────────────────────────────────────────────────────────── 
  CASH FLOWS FROM                                                               
  OPERATING ACTIVITIES:                                                         
  Net income               $                        56,035    $         51,773  
  Reconciliation to                                                             
  cash flows:                                                                   
  Depreciation and                                  28,240              25,553  
  amortization                                                                  
  Change in fair value                                                          
  of earnout                                         1,087              -1,048  
  liabilities                                                                   
  Operating leases                                   2,121               1,881  
  Gain on deferred                                  -1,689              -1,664  
  compensation assets                                                           
  Deferred income taxes                              1,131                   —  
  Stock compensation                                 4,168               4,587  
  expense                                                                       
  Other, net                                           -60                   8  
  Changes in operating                                                          
  accounts providing                                                            
  (using) cash:                                                                 
  Trade receivables                                 -9,949               5,140  
  Inventories                                      -14,550              -5,196  
  Accounts payable                                   9,676             -11,013  
  Accrued liabilities                               -6,320              -4,209  
  Lease liabilities                                 -2,376              -1,897  
  Income taxes                                       5,173               4,082  
  Other, net                                         2,801               3,034  
  Net cash provided by                                                          
  operating                                         75,488              71,031  
  activities                                                                    
  CASH FLOWS FROM                                                               
  INVESTING ACTIVITIES:                                                         
  Purchases of                                                                  
  property, plant, and                             -22,355             -24,342  
  equipment                                                                     
  Acquisitions                                      -5,200            -162,508  
  Proceeds from asset                                  517               1,037  
  disposals                                                                     
  Net cash used in                                 -27,038            -185,813  
  investing activities                                                          
  CASH FLOWS FROM                                                               
  FINANCING ACTIVITIES:                                                         
  Cash dividends                                    -8,136              -7,723  
  declared and paid                                                             
  New shares issued                                  1,681               1,609  
  Payroll taxes paid in                                                         
  exchange for                                      -5,143              -3,028  
  shares withheld                                                               
  Shares repurchased                               -18,646                   —  
  Payments on senior                                                            
  secured revolving                                -20,000             -40,000  
  loan                                                                          
  Payments for debt                                      —                -764  
  issuance costs                                                                
  Borrowings on senior                                                          
  secured revolving                                  5,000             170,000  
  loan                                                                          
  Other                                                -20                   —  
  Net cash (used in)                                                            
  provided by financing                            -45,264             120,094  
  activities                                                                    
  NET INCREASE IN CASH                                                          
  AND CASH                                           3,186               5,312  
  EQUIVALENTS                                                                   
  CASH AND CASH                                                                 
  EQUIVALENTS,                                       3,914               5,103  
  BEGINNING OF                                                                  
  PERIOD                                                                        
  CASH AND CASH                                                                 
  EQUIVALENTS, END OF      $                         7,100    $         10,415  
  PERIOD                                                                        
  SUPPLEMENTAL                                                                  
  DISCLOSURES OF CASH                                                           
  FLOW                                                                          
  INFORMATION                                                                   
  Cash paid for income     $                        14,512    $         13,980  
  taxes                                                                         
  Cash paid for            $                         5,480    $          7,182  
  interest                                                                      
  Noncash investing                                                             
  activities - capital     $                         2,273    $          1,568  
  expenditures in                                                               
  accounts payable                                                              
                                                                                
                                                                                
                                 HAWKINS, INC.                                  
                                                                                
                                                                                
                        REPORTABLE SEGMENTS (UNAUDITED)                         
                                                                                
                                 (In thousands)                                 
                                                                                
  Three                                                                         
  mont…                                                                         
  ended                                                                         
  Sept…                      Food &                                             
  27,      Water             Health            Indus…                           
  2026:    Treat…            Scien…            Solut…            Total          
 ────────────────────────────────────────────────────────────────────────────── 
  Sales    $       174,9…    $       76,679    $       62,177    $      313,8…  
  Cost                                                                          
  of                                                                            
  sales            -104,…            -57,3…            -49,2…           -211,…  
  -                                                                             
  mate…                                                                         
  Cost                                                                          
  of                                                                            
  sales            -18,8…            -4,432            -2,923           -26,1…  
  -                                                                             
  oper…                                                                         
  over…                                                                         
  Gross            51,749            14,897             9,960           76,606  
  prof…                                                                         
  Sell…                                                                         
  gene…                                                                         
  and              -23,4…            -7,941            -3,282           -34,7…  
  admi…                                                                         
  expe…                                                                         
  Oper…            28,272             6,956             6,678           41,906  
  inco…                                                                         
  Three                                                                         
  mont…                                                                         
  ended                                                                         
  Sept…                                                                         
  28,                                                                           
  2025:                                                                         
  Sales    $       150,9…    $       72,914    $       56,612    $      280,4…  
  Cost                                                                          
  of                                                                            
  sales            -88,8…            -53,1…            -45,1…           -187,…  
  -                                                                             
  mate…                                                                         
  Cost                                                                          
  of                                                                            
  sales            -18,8…            -4,280            -2,580           -25,6…  
  -                                                                             
  oper…                                                                         
  over…                                                                         
  Gross            43,261            15,481             8,901           67,643  
  prof…                                                                         
  Sell…                                                                         
  gene…                                                                         
  and              -22,0…            -8,084            -3,548           -33,7…  
  admi…                                                                         
  expe…                                                                         
  Oper…            21,190             7,397             5,353           33,940  
  inco…                                                                         
  Six                                                                           
  mont…                                                                         
  ended                                                                         
  Sept…                                                                         
  27,                                                                           
  2026:                                                                         
  Sales    $       333,2…    $       173,9…    $       122,3…    $      629,4…  
  Cost                                                                          
  of                                                                            
  sales            -198,…            -130,…            -97,1…           -426,…  
  -                                                                             
  mate…                                                                         
  Cost                                                                          
  of                                                                            
  sales            -37,1…            -9,062            -5,961           -52,1…  
  -                                                                             
  oper…                                                                         
  over…                                                                         
  Gross            97,245            34,172            19,196           150,6…  
  prof…                                                                         
  Sell…                                                                         
  gene…                                                                         
  and              -47,1…            -15,9…            -6,919           -70,0…  
  admi…                                                                         
  expe…                                                                         
  Oper…            50,098            18,203            12,277           80,578  
  inco…                                                                         
  Six                                                                           
  mont…                                                                         
  ended                                                                         
  Sept…                                                                         
  28,                                                                           
  2025:                                                                         
  Sales    $       300,4…    $       162,0…    $       111,1…    $      573,7…  
  Cost                                                                          
  of                                                                            
  sales            -177,…            -118,…            -87,9…           -384,…  
  -                                                                             
  mate…                                                                         
  Cost                                                                          
  of                                                                            
  sales            -35,4…            -8,295            -4,994           -48,7…  
  -                                                                             
  oper…                                                                         
  over…                                                                         
  Gross            87,008            34,829            18,168           140,0…  
  prof…                                                                         
  Sell…                                                                         
  gene…                                                                         
  and              -41,1…            -16,4…            -7,111           -64,7…  
  admi…                                                                         
  expe…                                                                         
  Oper…            45,852            18,364            11,057           75,273  
  inco…                                                                         
                                                                                
Forward-Looking Statements . Various remarks in this press release constitute
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. These statements include those relating to consumer demand for
products containing our ingredients and the impacts of those demands,
expectations for results in our business segments and the timing of our filings
with the Securities and Exchange Commission. These statements are not historical
facts, but rather are based on our current expectations, estimates and
projections, and our beliefs and assumptions. Forward-looking statements may be
identified by terms, including “anticipate,” “believe,” “can,” “could,”
“expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of
these terms or other comparable terms. These statements are not guarantees of
future performance and are subject to certain risks, uncertainties and other
factors, some of which are beyond our control and are difficult to predict.
Actual results may vary materially from those contained in forward looking
statements based on a number of factors, including, but not limited to, changes
in competition and price pressures, changes in demand and customer requirements
or processes for our products, availability of product and disruptions to
supplies, interruptions in production resulting from hazards, transportation
limitations or other extraordinary events outside our control that may
negatively impact our business or the supply chains in which we participate,
changes in imported products and tariff levels, the availability of products and
the prices at which they are available, the acceptance of new products by our
customers and the timing of any such acceptance, changes in product supplies,
the availability of target acquisitions, and changes in interest rates.
Additional information concerning potential factors that could affect future
financial results is included in our Annual Report on Form 10-K for the fiscal
year ended March 29, 2026 , as updated from time to time in amendments and
subsequent reports filed with the SEC. Investors should take such risks into
account when making investment decisions. Shareholders and other readers are
cautioned not to place undue reliance on forward-looking statements, which
reflect our management’s view only as of the date hereof. We do not undertake
any obligation to update any forward-looking statements.
Contacts: Jack Shufelt

Investor Relations, Mergers and Acquisitions and Treasury Director

612/617-8582

[email protected]

[email protected]

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HWKN/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.